Veterans with depression face a 14% higher risk of heart failure, says a Vanderbilt-led study analyzing over 3.4 million U.S. veterans, urging better depression care.

Embla today announced results from a 64-week real-world study presented at the European Congress on Obesity, tracking nearly 2,700 adults in a digital GLP-1 treatment program. The study found that ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...

Cosmetic Dermatology & MediSpa of NJ, a leading cosmetic dermatology center in New Jersey (with locations in Englewood, Wayne, and Newark), proudly announces a notable increase in demand for BodyTite, ...

Initiation of AERIAL trial accelerated by successful first close of Series A1 financing  LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured ...

The website and visualization provide a detailed state-by-state analysis of opioid-related laws, regulations, and guidance for K-12 schools to respond to opioid challenges. Key fe ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company developing innovative therapies for unmet medical needs, today announced compelling preclinical data for HT-KIT, its ...

TPX-100 is being developed as a potential disease-modifying osteoarthritis drug (DMOAD), a class of therapies that aim not only to alleviate symptoms but to slow or halt disease p ...

Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing as standard of care for all non-squamous ...

Early growth in the first two years has an impact on adult height and pubertal growth but little effect on when puberty ...